Wed, 23 Sep 2026

Immuno Cure

people moves

Hong Kong-based Immuno Cure BioTech names new CFO

FutureCFO Editors November 23, 2022

Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccines and immunotherapies,

Recent posts

SEON unveils Signal Intelligence expansion for fraud detection

A Day in the Life: Jerome Le Louer from SmeCFO

AI in Finance: The move from experimenting to deploying

BlackLine announces PCI DSS compliance validation for detokenisation service

Philippine tax watchdog teams up with IMF for better tax compliance system

A Day in the Life: Saurabh Chauhan from Peakflo

Subscribe